Sales Forecasts of Actigraphy Sensors & PSG Devices Market Reveal Positive Outlook Through 2022 – 2031 : Fact.MR

The US$ 1.78 billion actigraphy sensor and PSG devices market on course to grow at 4.3% in 2019, according to Fact.MR’s latest analysis. According to the study, actigraphy sensor and PSG devices market remains a highly consolidated landscape, with Tier I companies maintaining their hegemony despite the foray of new entrants.

According to the study, as a result of the convergence of healthcare and technology, new medical technology (MedTech) products are gaining ground. Growing consumer awareness about—and inclination towards—technologically advanced actigraphy sensor and PSG devices has attracted both, tech industry leaders and startups, to enter the healthcare industry with more innovative actigraphy sensor and PSG devices.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=2829

Growing Prevalence of Sleep Disorders Triggering Demand

The modern lifestyle has altered sleeping patterns, leading to an increase in the prevalence of various sleep disorders.

Right from minor sleep disturbances to major problems, such as insomnia, chronic sleep disorders have adverse impacts on consumers’ quality of life.

As actigraphy sensor and PSG devices make it simpler for users to monitor their sleep duration with more convenience and accuracy, it helps in diagnosing sleep diseases reliably and makes treatments more effective.

Thereby, consumers are seeking diagnostic services for the accurate treatments of sleep disorders, which is creating a high demand for actigraphy sensor and PSG devices in the healthcare sector.

Furthermore, ongoing research in the field of sleep disorder management to discover more efficient medicine and treatments for life-threatening sleep disorders is providing a boost to the applications of actigraphy sensor and PSG devices.

Standards and Stringent Regulatory Framework Influence Actigraphy Sensor and PSG Devices Manufacturing Strategies

In order to ensure consumers’ health and safety of devices, governing bodies across the globe have regulated the use of actigraphy sensor and PSG devices with strict guidelines and high standards for accreditation.

For instance, the American Academy of Sleep Medicine (AASM) recently published clinical practice guideline for the applications of actigraphy sensors in sleep monitoring devices.

AFor critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=2829

Polysomnography Devices to Remain the Gold Standard for Sleep Monitoring Systems

The Fact.MR study provides a thorough assessment on various macro and microeconomic factors that are shaping growth of the actigraphy sensor and PSG devices market. The study finds that polysomnography or PSG devices hold the largest, nearly 65% revenue share in the actigraphy sensor and PSG devices market, and the trend is likely to follow through the coming future.

Polysomnography provides a detailed evaluation of sleep-related data when it comes to medical cases, which remains the primary reason behind the growing preference for PSG devices over actigraphy sensors. In addition, the clinical practice guideline by the American Academy of Sleep Medicine on use of actigraphy for sleep disorders have declared that “actigraphy is not a substitute for polysomnography in clinical circumstances”.

The Fact.MR study provides comprehensive assessment of the future growth prospects of the actigraphy sensor and PSG devices market to predict that the market will grow at an incremental 4.6% value CAGR through 2026.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/2829

Polysomnography Devices to Remain the Gold Standard for Sleep Monitoring Systems

The Fact.MR study provides a thorough assessment on various macro and microeconomic factors that are shaping growth of the actigraphy sensor and PSG devices market. The study finds that polysomnography or PSG devices hold the largest, nearly 65% revenue share in the actigraphy sensor and PSG devices market, and the trend is likely to follow through the coming future.

Polysomnography provides a detailed evaluation of sleep-related data when it comes to medical cases, which remains the primary reason behind the growing preference for PSG devices over actigraphy sensors. In addition, the clinical practice guideline by the American Academy of Sleep Medicine on use of actigraphy for sleep disorders have declared that “actigraphy is not a substitute for polysomnography in clinical circumstances”.

The Fact.MR study provides comprehensive assessment of the future growth prospects of the actigraphy sensor and PSG devices market to predict that the market will grow at an incremental 4.6% value CAGE through 2026.

Read More Trending and Similar Reports from Fact.MR – https://www.prnewswire.com/news-releases/blood-collection-tubes-for-liquid-biopsy-sales-set-to-grow-at-12-through-2021-factmr-301245568.html

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Related Articles

Back to top button